We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length.
- Authors
Cacciamani, Andrea; Oddone, Francesco; Parravano, Mariacristina; Scarinci, Fabio; Nicola, Marta; Lofoco, Giorgio
- Abstract
Purpose: To evaluate the immediate and short-term effects of intravitreal injection of 1.25 mg/0.05 ml of bevacizumab on intraocular pressure related to different ocular axial lengths. Design: A prospective case series of consecutive patients referred to the Department of Ophthalmology, San Pietro-Fatebenefratelli Hospital, from September 2011 through January 2011. Methods: Twenty-five patients (10 men and 15 women, mean age 70.2 ± 8.98 years) scheduled for intravitreal injection of bevacizumab for the treatment of neovascular age-related macular degeneration were enrolled in this study. Axial length was measured preoperatively using IOLMaster. Intraocular pressure was measured before injection, after 1 min and after 15 min using Tono-Pen XL tonometry. Results: The mean intraocular pressure change following the intravitreal bevacizumab injection was 21.92 ± 6.95 mmHg after 1 min and 6.24 ± 3.77 mmHg after 15 min. The mean axial length of the examined eyes was 23.2 ± 1.06 mm. A good correlation was observed between the axial length and intraocular pressure rise after both 1 ( R = 0.752, p < 0.001) and 15 min ( R = 0.559, p < 0.001). Conclusions: Patients undergoing intravitreal injection of 0.05 ml of bevacizumab can be exposed to intraocular pressure increases correlated to ocular axial length.
- Subjects
BEVACIZUMAB; INTRAOCULAR pressure; INJECTIONS; ANTINEOPLASTIC agents; BODY fluid pressure
- Publication
Japanese Journal of Ophthalmology, 2013, Vol 57, Issue 1, p63
- ISSN
0021-5155
- Publication type
Article
- DOI
10.1007/s10384-012-0194-8